Wistar scientists develop new bispecific T cell engager to target ovarian cancer
Wistar scientists have developed a new type of bispecific T cell engager, or BTE, that is effective against…
New tumor organoids strengthen precision oncology research
Significant advances have been made in the development of patient-derived tumor “organoids” for preclinical research, in two new…
Gut microbial metabolites may shape vulnerability to stress-related mental disorders
Jul 20 2026 From short-chain fatty acids to bile acids, researchers trace how microbial chemistry could influence brain…
Blood p-tau217 levels signal cognitive impairment risk years before symptoms emerge
A six-cohort analysis links higher baseline p-tau217 to rising 5- and 10-year risks, bringing presymptomatic risk models closer…
First clinical trial evaluates stem cell therapy for Huntington’s disease
An update on the first clinical trial evaluating a pluripotent stem cell-derived neural stem cell therapy for Huntington’s…
Experimental compound BA-101 overcomes chemotherapy resistance in glioblastoma
Scientists have identified a promising new strategy to tackle one of the biggest obstacles in treating glioblastoma, one…
BCG vaccine may remodel the human brain’s immune environment
New research led by Mass General Brigham investigators suggests that the Bacillus Calmette-Guérin (BCG) vaccine – which is…
Tailored drug combinations improve outcomes for treatment-resistant advanced melanoma
A new study led by researchers at The University of Texas MD Anderson Cancer Center has identified a way to tailor drug combinations based on specific…
Study potential new therapeutic strategy for patients with ATRX-mutant gliomas
A new study from researchers at The University of Texas MD Anderson Cancer Center has uncovered how one of…
Cannabidiol shows preclinical promise for anxiety, depression and cognition
A new Molecular Psychiatry meta-analysis suggests CBD may improve emotional behavior and cognition in animal models, but researchers…
AI-guided microneedle patch changes shape to heal chronic wounds
Chronic wounds remain a major healthcare challenge, especially for people with diabetes, who often experience delayed healing, persistent…
Engineered silica nanoparticles destroy prostate tumors in preclinical study
Prostate-targeted, engineered nanoparticles made of amorphous silica are effective in killing prostate tumors directly while enhancing anti-tumor immunity,…